MyoKardia

MyoKardia is pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction.
Type
Public
HQ
South San Francisco, US
Size (employees)
61 (est)
MyoKardia is headquartered in South San Francisco, US

Key People at MyoKardia

Charles Homcy

Charles Homcy

Interim CEO and Board Member
Neil Kumar

Neil Kumar

Interim Vice President of Business Development

MyoKardia Office Locations

MyoKardia has office in South San Francisco
South San Francisco, US

MyoKardia Metrics

MyoKardia Summary

Market capitalization

$457.1 m

Closing share price

$14.6
MyoKardia's current market capitalization is $457.1 m.

MyoKardia Market Value History

We estimate that MyoKardia's current employees are approximately 21% female and 79% male.

MyoKardia Online Presence

MyoKardia Company Life

You may also be interested in